Evaluation of Targeted Axillary Lymph Node Dissection in Node Positive Breast Cancer Patients Post Neo Adjuvant Therapy
Condition(s):Node-positive Breast CancerLast Updated:January 9, 2023Not yet recruiting
Hide Studies Not Open or Pending
Condition(s):Node-positive Breast CancerLast Updated:January 9, 2023Not yet recruiting
Condition(s):Breast CancerLast Updated:April 9, 2021Completed
Condition(s):Breast Cancer LymphedemaLast Updated:December 21, 2023Active, not recruiting
Condition(s):Breast Cancer; Chronic Pain; Intercostobrachial Nerve InjuryLast Updated:February 1, 2022Unknown status
Condition(s):Breast Cancer; Chemotherapy; Sentinel Lymph Node; Axillary Lymph Nodes Dissection; Radiotherapy Side EffectLast Updated:March 1, 2024Recruiting
Condition(s):Breast CancerLast Updated:April 5, 2018Withdrawn
Condition(s):Lymphedema; Breast Cancer; MelanomaLast Updated:October 24, 2023Active, not recruiting
Condition(s):Invasive Breast CancerLast Updated:January 11, 2024Active, not recruiting
Condition(s):Breast NeoplasmsLast Updated:November 22, 2012Unknown status
Condition(s):Breast CancerLast Updated:January 23, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.